Vaccination Practices and Knowledge Among Adults with Hemoglobinopathies in Greece: a Nationwide Survey

Overview

Journal Ther Adv Vaccines Immunother

Publisher Sage Publications

Date 2024 Sep 24

PMID 39314901

Authors

Sophia Delicou

Konstantinos Manganas

Aikaterini Xydaki

Loukia Evliati

Ioanna Myrilla

Leonidas Rubatis

Stavroula Kostaridou

Affiliations

Soon will be listed here.

Abstract

Background: Hemoglobinopathies, such as sickle cell disease and thalassemia, are genetic disorders that affect hemoglobin structure or production, leading to various health complications, including an increased risk of infections. Vaccinations play a crucial role in managing these conditions by providing essential protection against preventable diseases. Ensuring timely and appropriate immunizations is vital for reducing infection-related morbidity and improving the overall health and quality of life for affected individuals.

Objectives: Our objective was to assess vaccination coverage, as well as knowledge, attitudes, and practices toward vaccination in Greek patients with hemoglobinopathies.

Design And Methods: A nationwide survey of hemoglobinopathy patients in Greece using a 37-item questionnaire was conducted anonymously via Google Forms. It covered demographics, previous vaccinations, vaccine-preventable infections, beliefs about vaccines, and antibiotic prophylaxis post-splenectomy. The survey was distributed through Thalassemia and Sickle Cell Units and organizations.

Results: Participants were predominantly university-educated married women aged 30-50 years with transfusion-depended thalassemia ( = 149, 60.5%) or sickle cell anemia ( = 52, 21.1%). Reported childhood vaccination rates aligned with Greece's national immunization program. However, adult coverage was suboptimal across all age groups for measles (10%), varicella (27%), zoster (2% for over 50 years old individuals), hepatitis A (13.9% of those with chronic liver disease) and hepatitis B (41%), pneumococcal (81.3%), meningococcal (37%), tetanus (20.3%), and influenza (67.1%) vaccines compared to guidelines. Participants relied predominantly on healthcare providers for vaccine information but perceived limited engagement. Those over age 50 demonstrated lower adult vaccination rates and higher misconceptions compared to younger cohorts.

Conclusion: Addressing educational and access gaps could help protect this vulnerable population. Our findings highlight the need for coordinated efforts to optimize adult immunization for those with hemoglobinopathies.

References

Ricerca B, di Girolamo A, Rund D . Infections in thalassemia and hemoglobinopathies: focus on therapy-related complications. Mediterr J Hematol Infect Dis. 2011; 1(1):e2009028. PMC: 3033166. DOI: 10.4084/MJHID.2009.028. View

Iolascon A, De Franceschi L, Muckenthaler M, Taher A, Rees D, De Montalembert M . EHA Research Roadmap on Hemoglobinopathies and Thalassemia: An Update. Hemasphere. 2019; 3(3):e208. PMC: 6746021. DOI: 10.1097/HS9.0000000000000208. View

Marin M, Broder K, Temte J, Snider D, Seward J . Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2010; 59(RR-3):1-12. View

Burrows N, Hora I, Geiss L, Gregg E, Albright A . Incidence of End-Stage Renal Disease Attributed to Diabetes Among Persons with Diagnosed Diabetes - United States and Puerto Rico, 2000-2014. MMWR Morb Mortal Wkly Rep. 2017; 66(43):1165-1170. PMC: 5689212. DOI: 10.15585/mmwr.mm6643a2. View

. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine from the Advisory Committee on Immunization Practices, 2010. MMWR Morb Mortal Wkly Rep. 2011; 60(1):13-5. View

. Recommendations from the National Vaccine Advisory committee: standards for adult immunization practice. Public Health Rep. 2014; 129(2):115-23. PMC: 3904889. DOI: 10.1177/003335491412900203. View

Beytout J, Launay O, Guiso N, Fiquet A, Baudin M, Richard P . Safety of Tdap-IPV given one month after Td-IPV booster in healthy young adults: a placebo-controlled trial. Hum Vaccin. 2008; 5(5):315-21. DOI: 10.4161/hv.5.5.6911. View

Preaud E, Durand L, Macabeo B, Farkas N, Sloesen B, Palache A . Annual public health and economic benefits of seasonal influenza vaccination: a European estimate. BMC Public Health. 2014; 14:813. PMC: 4141103. DOI: 10.1186/1471-2458-14-813. View

Liang J, Tiwari T, Moro P, Messonnier N, Reingold A, Sawyer M . Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2018; 67(2):1-44. PMC: 5919600. DOI: 10.15585/mmwr.rr6702a1. View

10.

Tsiligianni I, Bouloukaki I, Papazisis G, Paganas A, Chatzimanolis E, Kalatharas M . Vaccination coverage and predictors of influenza, pneumococcal, herpes zoster, tetanus, measles, and hepatitis B vaccine uptake among adults in Greece. Public Health. 2023; 224:195-202. DOI: 10.1016/j.puhe.2023.09.002. View

11.

Loukopoulos D . Haemoglobinopathies in Greece: prevention programme over the past 35 years. Indian J Med Res. 2011; 134:572-6. PMC: 3237258. View

12.

. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2012; 61(40):816-9. View

13.

Brousse V, Makani J, Rees D . Management of sickle cell disease in the community. BMJ. 2014; 348:g1765. PMC: 5612384. DOI: 10.1136/bmj.g1765. View

14.

Wong W, Powars D, Chan L, Hiti A, JOHNSON C, Overturf G . Polysaccharide encapsulated bacterial infection in sickle cell anemia: a thirty year epidemiologic experience. Am J Hematol. 1992; 39(3):176-82. DOI: 10.1002/ajh.2830390305. View

15.

Wong W, Overturf G, Powars D . Infection caused by Streptococcus pneumoniae in children with sickle cell disease: epidemiology, immunologic mechanisms, prophylaxis, and vaccination. Clin Infect Dis. 1992; 14(5):1124-36. DOI: 10.1093/clinids/14.5.1124. View

16.

Modell B, Darlison M . Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ. 2008; 86(6):480-7. PMC: 2647473. DOI: 10.2471/blt.06.036673. View

17.

Grohskopf L, Alyanak E, Broder K, Walter E, Fry A, Jernigan D . Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2019-20 Influenza Season. MMWR Recomm Rep. 2019; 68(3):1-21. PMC: 6713402. DOI: 10.15585/mmwr.rr6803a1. View

18.

Servey J, Reamy B, Hodge J . Clinical presentations of parvovirus B19 infection. Am Fam Physician. 2007; 75(3):373-6. View

19.

Rees D, Williams T, Gladwin M . Sickle-cell disease. Lancet. 2010; 376(9757):2018-31. DOI: 10.1016/S0140-6736(10)61029-X. View

20.

Wendt A, Brintrup J, Waid J, Kader A, Lambrecht N, Gabrysch S . Thalassemia and hemoglobinopathy prevalence in a community-based sample in Sylhet, Bangladesh. Orphanet J Rare Dis. 2023; 18(1):192. PMC: 10355052. DOI: 10.1186/s13023-023-02821-3. View